Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: Clinical practice guidelines based on field experience and review of the literature

Transfusion

Volumn 47, Issue 12, 2007, Pages 2276-2289

  Kanold, Justyna ^a   Merlin, Etienne ^b   Halle, Pascale ^b   Paillard, Catherine ^b   Marabelle, Aurelien ^b   Rapatel, Chantal ^b   Evrard, Bertrand ^b   Berger, Claire ^b   Stephan, Jean Louis ^b   Galambrun, Claire ^b   Piguet, Christophe ^b   D'Incan, Michel ^b   Bordigoni, Pierre ^b   Deméocq, François ^b  

^a HÔTEL DIEU   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIAZEPAM; GLUCONATE CALCIUM; INOLIMOMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NALBUPHINE; PENTOSTATIN; RITUXIMAB; STEROID; TACROLIMUS; THALIDOMIDE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BODY WEIGHT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; IMMUNOLOGY; INFORMATION PROCESSING; LONG TERM CARE; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PHOTOCHEMOTHERAPY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PUVA; TREATMENT RESPONSE; VASCULAR ACCESS;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; PHOTOPHERESIS; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 36348960099     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01469.x     Document Type: Article

References (42)

1. Giebel S, Giorgiani G, Martinetti M, Zecca M, Maccario R, Salvaneschi L, Holowiecki J, Locatelli F. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Bone Marrow Transplant 2003 31 : 987 93.
2. Bunin N, Carston M, Wall D, Adams R, Casper J, Kamani N, King R the National Marrow Donor Program Working Group. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 2002 99 : 3151 7.
3. Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S, Pillon M, Perotti C, Del Fante C, Faraci M, Rivabella L, Calore E, De Stefano P, Zecca M, Giorgiani G, Brugiolo A, Balduzzi A, Dini G, Zanesco L, Dall'Amico R. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003 122 : 118 27.
4. Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005 105 : 3802 11.
5. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994 14 : 845 8.
6. Edelson RL. Photopheresis: a new therapeutic concept. Yale J Biol Med 1989 62 : 565 77.
7. Costanzo-Nordin MR, Hubbell EA, O 'Sullivan EJ, Johnson MR, Mullen GM, Heroux AL, Kao WG, McManus BM, Pifarre R, Robinson JA. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992 53 : 808 15.
8. Sunder-Plassman G, Druml W, Steininger R, Honigsmann H, Knobler R. Renal allograft rejection controlled by photopheresis. Lancet 1995 346 : 506.
9. Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall'Amico R, Dorent R, Rogers JG, Radovancević B, Taylor DO, Jeevanandam V, Marboe CC. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998 339 : 1744 51.
10. Laroche L, Edelson RL, Perez M, Berger CL. Antigen-specific tolerance induced by autoimmunization with photoinactivated syngeneic effector cells. Ann N Y Acad Sci 1991 636 : 113 23.
11. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D, Schwarz T. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005 174 : 5968 76.
12. Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, Smith V, Khouri I, Giralt S, de Lima M, Hsu Y, Ghosh S, Neumann J, Andersson B, Qazilbash M, Hymes S, Kim S, Champlin R, Donato M. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 2006 107 : 3074 80.
13. Foss FM, DiVenuti GM, Chin K, Grodman H, Klein A, Chan G, Stiffler K, Miller KB. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005 35 : 1187 93.
14. Rubegni P, Cuccia A, Sbano P, Cevenini G, Carcagnì MR, D'Ascenzo G, De Aloe G, Guidi S, Guglielmelli P, Marotta G, Lauria F, Bosi A, Fimiani M. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005 130 : 271 5.
15. Bisaccia E, Palangio M, Gonzalez J, Adler KR, Rowley SD, Goldberg SL. Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy. Bone Marrow Transplant 2003 31 : 291 4.
16. Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003 102 : 1217 23.
17. D'Incan M, Kanold J, Halle P, De Lumley L, Souteyrand P, Demeocq F. Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases. Ann Dermatol Venereol 2000 127 : 166 70.
18. Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, Keil F, Hönigsmann H, Knobler RM. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. Blood 2000 96 : 2426 31.
19. Perotti C, Torretta L, Viarengo G, Roveda L, Bernuzzi S, Carbone S, Del Fante C, La Torre R, Locatelli F, Bonetti F, Gabba P, Bellosta M, Salvaneschi L. Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures. Haematologica 1999 84 : 237 41.
20. Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Giorgiani G, Del Fante C, Bergamaschi P, Maccario R, Pession A, Locatelli F. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001 41 : 1299 305.
21. Halle P, Paillard C, D'Incan M, Bordigoni P, Piguet C, De Lumley L, Stephan JL, Berger M, Rapatel C, Deméocq F, Kanold J. Successful extracorporeal photochemotherapy for chronic graft-versus-host disease in pediatric patients. J Hematother Stem Cell Res 2002 11 : 501 12.
22. Kanold J, Paillard C, Halle P, D'Incan M, Bordigoni P, Demeocq F. Extracorporeal photochemotherapy for graft versus host disease in pediatric patients. Transfus Apher Sci 2003 28 : 71 80.
23. Kanold J, Messina C, Halle P, Locatelli F, Lanino E, Cesaro S, Deméocq F Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005 35 Suppl 1 : S69 71.
24. McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R British Photodermatology Group; UK Skin Lymphoma Group. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006 154 : 7 20.
25. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003 54 : 29 52.
26. Andreu G, Leon A, Heshmati F, Tod M, Menkes CJ, Baudelot J, Laroche L. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders. Transfus Sci 1994 15 : 443 54.
27. Jacob MC, Manches O, Drillat P, Richard MJ, Plumas J, Chaperot L, Hegelhofer H, Garban F, Gressin R, Favrot M, Bensa JC, Pernollet M. Quality control for the validation of extracorporeal photopheresis process using the Vilbert-Lourmat UV-A irradiation's system. Transfus Apher Sci 2003 28 : 63 70.
28. Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P, Mitterbauer M, Rabitsch W, Schulenburg A, Kalhs P. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica 2006 91 : 405 8.
29. Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD, Foley R, Socie G, Carter S, Couriel D, Schultz KR, Flowers ME, Filipovich AH, Saliba R, Vogelsang GB, Pavletic SZ, Lee SJ, Design of Clinical Trials Working Group. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group report. Biol Blood Marrow Transplant 2006 12 : 491 505.
30. Coyle TS, Nam TK, Camouse MM, Stevens SR, Baron ED. Steroid-sparing effect of extracorporeal photopheresis in the treatment of graft-vs-host disease. Arch Dermatol 2004 140 : 763 4.
31. Fimiani M, Di Renzo M, Rubegni P. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol 2004 150 : 1055 60.
32. Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL. Transimmunization, a novel approach for tumor immunotherapy. Transfus Apher Sci 2002 26 : 205 16.
33. Schooneman F. Extracorporeal photopheresis technical aspects. Transfus Apher Sci 2003 28 : 51 61.
34. Perseghin P, Dassi M, Balduzzi A, Rovelli A, Bonanomi S, Uderzo C. Mononuclear cell collection in patients undergoing extra-corporeal photo-chemotherapy for acute and chronic graft-vs.-host-disease (GvHD): comparison between COBE Spectra version 4.7 and 6.0 (AutoPBSC). J Clin Apher 2002 17 : 65 71.
35. Bensinger W, Petersen FB, Banaji M, Buckner CD, Clift R, Slichter SJ, Storb R, Thomas ED. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission. Bone Marrow Transplant 1989 4 : 409 14.
36. Pihlstedt P, Paulin T, Sundberg B, Nilsson B, Ringden O. Blood transfusion in marrow graft recipients. Ann Hematol 1992 65 : 66 70.
37. Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann N Y Acad Sci 2001 941 : 1 11.
38. Duzovali O, Chan KW. Intensive extracorporeal photochemotherapy in pediatric patients with chronic graft-versus-host disease (cGVHD). Pediatr Blood Cancer 2007 48 : 218 21.
39. Marshall SR. Technology insight: ECP for the treatment of GvHD - can we offer selective immune control without generalized immunosuppression? Nat Clin Pract Oncol 2006 3 : 302 14.
40. Lim HW, Edelson RL. Photopheresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995 9 : 1117 26.
41. Suchin KR, Cassin M, Washko R, Nahass G, Berkson M, Stouch B, Vowels BR, Rook AH. Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol 1999 41 : 980 6.
42. Rossetti F, Dall'Amico R, Crovetti G, Messina C, Montini G, Dini G, Locatelli F, Argiolu F, Miniero R, Zacchello G. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant 1996 18 Suppl 2 : 175 81.